# Zhengye Biotechnology Holdings Inc. (ZYBT)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Price:** $0.90 (+1.05%)

> Zhengye Biotechnology Holdings Inc. is a holding company incorporated in the Cayman Islands, with its underlying business focused on the research, development, manufacturing, and sales of veterinary vaccines, emphasizing those for livestock. The company offers a diverse portfolio of 46 veterinary vaccines targeting swine, cattle, goats, sheep, poultry, and dogs, enhancing animal health through innovative solutions. Its products reach 29 provincial regions across China and are exported to international markets including Vietnam, Pakistan, and Egypt, with specific vaccines like Newcastle Disease and Avian Influenza varieties serving key overseas demand. Zhengye Biotechnology Holdings Inc. serves direct-end users such as livestock farmers and local governments, as well as domestic and exporting distributors. The business relies on intellectual property protections, including 10 registered trademarks, 45 patents, three domain names, and six copyrights in China. Founded in 2004 and headquartered in Jilin City, Jilin Province, China, it plays a vital role in the veterinary pharmaceuticals sector, supporting livestock health and agricultural productivity.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/ZYBT)